Drug details

Haegarda (c1 esterase inhibitor subcutaneous [human] injection)

type of Immunomodulators

Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) is a plasma-derived concentrate of C1 Esterase Inhibitor (Human) (C1-INH) indicated for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in adolescent and adult patients.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• lightheadedness,
• confusion,
• fast heartbeats,
• wheezing,
• chest tightness,
• blue lips or gums,
• sudden numbness or weakness on one side of the body,
• pain, swelling, warmth, or redness in an arm or leg,
• sudden severe headache,
• fast heart rate
• problems with vision, speech, or balance,
• chest pain while taking deep breaths, and

The following drugs are related to Haegarda, either as a replacement or used together:

• Orladeyo (berotralstat capsules)
• Ruconest (c1 esterase inhibitor [recombinant] intravenous injection)
• Danocrine (danazol)
• Sajazir (icatibant injection, for subcutaneous use)
• Takhzyro (lanadelumab-flyo injection)